Filippo Drago

Filippo Drago

Filippo Drago (born 5 December 1954 in Enna, Italy) is an Italian pharmacologist, neurologist and psychiatrist.

He has played several functions in international pharmacological societies, such as President of Federation of European Pharmacological Societies[1] and member of International Union of Basic and Clinical Pharmacology (IUPHAR) nominating committee.

In September 2015, Prof. Filippo Drago has been appointed as chairman of the Neuropsychopharmacology Section of International Union of Basic and Clinical Pharmacology.[2]

Filippo Drago is author of several patents in the field of pharmacology and of more than 380 papers published in peer-reviewed journals.[3]

Career

Filippo Drago is a Professor of Pharmacology and Director of the Department of Biomedical and Biotechnological Sciences at the University of Catania, Italy.[4] He obtained the Medical Doctor Degree in 1978 in the same University and obtained a PhD in Pharmacology in 1982 at the University of Utrecht, in the Netherlands, working with David de Wied.[1]

Drago's main research interests are in the fields of Ocular Pharmacology and Neuropsychopharmacology. He was a visiting scientist at Utrecht University, Szeged University (Hungary), Weizmann Institute of Science in Israel, the Department of Psychiatry in the University of North Carolina at Chapel Hill (USA).[4]

In the last decade he has also worked in the field of Pharmacovigilance and Pharmacoeconomics. He was a member of the Scientic Board of the Italian institutional drug agency Agenzia Italiana del Farmaco (AIFA) from 2004 to 2009[5] and is a member of the Board for Pricing and Reimbursement of AIFA since 2012.[6] He was the Director of the International PhD Program in Neuropharmacology (2002-2013) and he is the director of the Master Course in Drug Regulatory Affairs at the University of Catania's Medical School.[7]

Drago has been President of EPHAR for the years 2012-2014.[1]

He is also the President of the Italian branch of the Association for Research in Vision and Ophthalmology (ARVO), IT-ARVO.[8] and was awarded the "Silver Fellow" medal by ARVO at the 2014 ARVO annual meeting in Orlando.[9]

In 2014, Filippo Drago was awarded the Order of International Merit of Blood, by the International Federation of Blood Donor Organizations.[10]

During the 17th World Congress of Basic and Clinical Pharmacology in Cape Town, South Africa, Filippo Drago was announced among the recipients of the Rodolfo Paoletti Medal for Distinction in European Pharmacology.[11]

In 2015, Filippo Drago has been elected Vice President of the Association for Ocular Pharmacology and Therapeutics (AOPT), an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications.[12]

References

  1. 1 2 3 "EPHAR Executive Committee". EPHAR. Retrieved 8 September 2015.
  2. "Neuropsychopharmacology IUPHAR". IUPHAR. Retrieved 25 October 2015.
  3. "Filippo Drago". Scopus. Retrieved 25 October 2015.
  4. 1 2 "Filippo Drago" (in Italian). University of Catania. Retrieved 8 August 2015.
  5. "Composizione di strutture operanti in seno all’Agenzia Italiana del Farmaco (AIFA)" (PDF). Bollettino SIFO (in Italian) 5: 276–277. 2014. doi:10.1704/83.898. Retrieved 8 September 2015.
  6. "Aifa. Definiti i componenti regionali della Cts e del Cpr" (in Italian). Quotidianosanita.it. 20 April 2012. Retrieved 8 August 2015.
  7. "Master in Discipline Regolatorie del Farmaco". University of Catania. Retrieved 8 September 2015.
  8. "ARVONews Fall 2014". ARVO.org. Retrieved 2014.
  9. "2014 ARVO Fellows". ARVO.org. Archived from the original on 7 November 2014. Retrieved 2014.
  10. "Order for the International Merit of Blood". International Federation of Blood Donor Organizations. Retrieved 8 August 2015.
  11. "The Rodolfo Paoletti Medal". The Federation of European Pharmacological Societies. Retrieved 8 August 2015.
  12. "Board of Directors". Association for Ocular Pharmacology and Therapeutics. Retrieved 8 August 2015.

External links

This article is issued from Wikipedia - version of the Thursday, February 25, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.